2025 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
2025 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
2025 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI) - ATMP
Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI)
EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 5: Technical specifications
List of withdrawn medicinal products in accordance with Art. 123(4) of the Directive (1 January - 31 December 2025)
PSUSA/00001324/202505
PSUSA/00001040/202507
PSUSA/00002149/202505
PSUSA/00001672/202508
Human medicines European public assessment report (EPAR): Deltyba, delamanid, Date of authorisation: 27/04/2014, Date of refusal: 25/07/2013, Revision: 28, Status: Authorised